8-23224967-G-T
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_003844.4(TNFRSF10A):c.95C>A(p.Ala32Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000104 in 1,446,688 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_003844.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TNFRSF10A | NM_003844.4 | c.95C>A | p.Ala32Asp | missense_variant | 1/10 | ENST00000221132.8 | NP_003835.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TNFRSF10A | ENST00000221132.8 | c.95C>A | p.Ala32Asp | missense_variant | 1/10 | 1 | NM_003844.4 | ENSP00000221132 | P1 | |
TNFRSF10A | ENST00000613472.1 | c.31+64C>A | intron_variant | 1 | ENSP00000480778 | |||||
TNFRSF10A-DT | ENST00000517774.1 | n.421+76G>T | intron_variant, non_coding_transcript_variant | 4 |
Frequencies
GnomAD3 genomes Cov.: 30
GnomAD3 exomes AF: 0.0000136 AC: 3AN: 220598Hom.: 0 AF XY: 0.0000166 AC XY: 2AN XY: 120524
GnomAD4 exome AF: 0.0000104 AC: 15AN: 1446688Hom.: 0 Cov.: 31 AF XY: 0.00000835 AC XY: 6AN XY: 718490
GnomAD4 genome Cov.: 30
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | May 20, 2024 | The c.95C>A (p.A32D) alteration is located in exon 1 (coding exon 1) of the TNFRSF10A gene. This alteration results from a C to A substitution at nucleotide position 95, causing the alanine (A) at amino acid position 32 to be replaced by an aspartic acid (D). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at